Identifying Key Hub Genes that Attribute Varying Host Responses: A Longitudinal RNA-seq Analysis of SARS-CoV-2 Delta and Omicron Infections
Preprint
Abstract
Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has severely impacted global health, with different Variants of Concern (VOCs) resulting in varied clinical outcomes. Among these, the Delta and Omicron variants have drawn significant attention due to their distinct characteristics—Delta is associated with higher virulence and Omicron has greater transmissibility but reduced severity. This study compares host immune responses to the Delta and Omicron variants using RNA-seq data from infected primary human airway epithelial cells. Both variants triggered a robust antiviral innate immune response by 2 days post-infection (dpi). However, Omicron was found to elicit a more rapid immune response, showing pathway enrichment at 1 dpi. In contrast, Delta displayed no immune-related pathway activation within the first 24 hours, suggesting it may evade early immune detection, promoting increased viral replication. By 3 dpi, Delta induced a more aggressive immune response, particularly in pathways related to cell death and pro-inflammatory signaling, such as “programmed cell death” and “regulation of cell death.” Weighted gene co-expression network analysis revealed distinct immune-related genes: Delta infections were characterized by hub genes like MYD88 and IL1R1 involved in pro-inflammatory responses, HLA-A & B, NLRC5 and PSMB9 involved in antigen presentation and TNSF10 and IFR1 involved in pro-apoptotic processes. Conversely, Omicron infections were marked by hub genes such as CXCL1 and CXCL8 involved in immune cells recruitment, MET and LYN involved in reducing hyperinflammatory responses and maintaining immune balance, and IFI44, EIF2AK2 and IFIT5 responsible for the sensing of viral RNA among others.Keywords
This publication has 39 references indexed in Scilit:
- Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epitheliaiScience, 2023
- Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamstersMed, 2022
- Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, CanadaJAMA, 2022
- SARS‐CoV‐2 Omicron variant: Characteristics and preventionMedcomm, 2021
- Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adultsiScience, 2021
- SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathwayiScience, 2021
- Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approachBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventionsAutoimmunity Reviews, 2020
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- Interferon-stimulated genes and their antiviral effector functionsCurrent Opinion in Virology, 2011